GlassScriptPhysician profile
Andrew M Mcneely
NPI 1801225032
$3,260.82
in general payments reported to CMS, 2019-2025
23 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,052 · 2022: $837 · 2023: $401 · 2024: $760 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $584.23 | 2021-2024 | Fasenra |
| Abbvie INC. | $554.52 | 2021-2024 | |
| Horizon Therapeutics Plc | $245.82 | 2021 | |
| Optinose US, INC. | $242.48 | 2021-2025 | |
| Organon LLC | $234.93 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.99 | 2024 | |
| Nevro Corp. | $136.13 | 2024 | Senza |
| Medtronic, INC. | $126.90 | 2021-2025 | Venaseal |
| Ultragenyx Pharmaceutical INC. | $125.00 | 2022 | |
| Glaxosmithkline, LLC. | $124.40 | 2023 | Benlysta |
| Abbott Laboratories | $119.69 | 2021 | |
| Esperion Therapeutics, INC. | $109.47 | 2021 | |
| Alexion Pharmaceuticals, INC. | $91.47 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.07 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $80.80 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $61.56 | 2021 | |
| Intuity Medical INC | $48.50 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Amgen INC. | $45.67 | 2024 | Otezla |
| Inspire Medical Systems, INC. | $22.29 | 2023 | Inspire |
| Cranial Technologies, INC | $22.13 | 2025 | Doc Band |
| Phadia US INC. | $19.61 | 2022 | |
| Biogen, INC. | $18.02 | 2025 | Zurzuvae |
| Sanofi Pasteur INC. | $14.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mcneely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.